Company intelligence / Profile preview

Axcelon Biopolymers

Ownership: Private
Development stage: Commercial

Overview

Axcelon Biopolymers has developed proprietary bacterial nanocellulose-based products for advanced wound care ("Nanoderm", licensed by Health Canada), with additional pipeline programs targeting cardiovascular grafts, tympanic membrane repair, and other medical device applications. The company’s devices are primarily in early development stages except for the lead woundcare product which is commercially available in some markets

Therapeutic areas: OtherDermatologyCardiovascularOphthalmologyInfectious Diseases
Modalities: DeviceHydrogel-based drug delivery therapy (Bacterial nanocellulose-based wound dressings and scaffolds)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Nanoderm

Commercial

Indications: Wound healing, Second degree burns, Dermabrasions, Acute wounds, Chronic wounds

Partnerships

Arylide Life Sciences Inc. (COVID-related biotech mask collaboration)Office of Applied Research and Innovation at Collège La Cité

Beyond the preview

Go deeper on Axcelon Biopolymers.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axcelon Biopolymers.

Explore the full profile